Literature DB >> 15750664

Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine,is associated with dementia in elderly Latinos.

A K Campbell1, W J Jagust, D M Mungas, J W Miller, R Green, M N Haan, L H Allen.   

Abstract

The relationship between B vitamin status and cognitive function has been of interest for many years. There is evidence of relationships between intake and status of folate and vitamin B-12 with neurological, cognitive, and memory impairment, but results have been inconsistent. Plasma B-12, erythrocyte folate, methylmalonic acid,and homocysteine were evaluated as predictors of cognitive function in a large population based sample of Latino elderly living in the Sacramento, California region. The hypothesis tested was that low folate and/or B-12 status predicts cognitive function impairment and dementia. Logistic regression was used to examine the differences in B-vitamin status by cognitive function category. Erythrocyte folate was related to dementia after controlling for age, gender, education, income, diabetes diagnosis, serum creatinine, and depressive symptoms. The highest prevalence of low erythrocyte folate occurred in the Dementia group and was significantly higher than in the Normal group. Plasma B-12, MMA, Hcy, and prevalence of a normal values for these variables, were not significantly different among the cognitive function classes. We conclude that folate status is associated with dementia but that more research is needed on the relationship between vitaminB-12 status, Hcy and cognitive function to explore possible associations with these parameters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750664

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  3 in total

1.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

2.  Effectiveness and safety of donepezil in Hispanic patients with Alzheimer's disease: a 12-week open-label study.

Authors:  Oscar L Lopez; Joan A Mackell; Yijun Sun; Laurent M Kassalow; Yikang Xu; Thomas McRae; Honglan Li
Journal:  J Natl Med Assoc       Date:  2008-11       Impact factor: 1.798

Review 3.  Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis.

Authors:  May A Beydoun; Hind A Beydoun; Alyssa A Gamaldo; Alison Teel; Alan B Zonderman; Youfa Wang
Journal:  BMC Public Health       Date:  2014-06-24       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.